1. Home
  2. MGIC vs RZLT Comparison

MGIC vs RZLT Comparison

Compare MGIC & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magic Software Enterprises Ltd.

MGIC

Magic Software Enterprises Ltd.

HOLD

Current Price

$24.95

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.89

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIC
RZLT
Founded
1983
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
187.3M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
MGIC
RZLT
Price
$24.95
$2.89
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$18.00
$9.14
AVG Volume (30 Days)
27.4K
6.4M
Earning Date
03-10-2026
02-11-2026
Dividend Yield
2.33%
N/A
EPS Growth
16.15
N/A
EPS
0.81
N/A
Revenue
$603,216,000.00
N/A
Revenue This Year
$12.87
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
$31.90
N/A
Revenue Growth
12.65
N/A
52 Week Low
$11.65
$1.07
52 Week High
$28.00
$11.46

Technical Indicators

Market Signals
Indicator
MGIC
RZLT
Relative Strength Index (RSI) 41.35 42.12
Support Level $27.27 $2.69
Resistance Level $28.00 $2.92
Average True Range (ATR) 0.48 0.26
MACD -0.27 0.32
Stochastic Oscillator 13.79 90.22

Price Performance

Historical Comparison
MGIC
RZLT

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: